Product NDC: | 61748-202 |
Proprietary Name: | Erythromycin |
Non Proprietary Name: | Erythromycin |
Active Ingredient(s): | 20 mg/mL & nbsp; Erythromycin |
Administration Route(s): | TOPICAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61748-202 |
Labeler Name: | VersaPharm Incorporated |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090215 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100801 |
Package NDC: | 61748-202-60 |
Package Description: | 60 PACKET in 1 JAR (61748-202-60) > .8 mL in 1 PACKET |
NDC Code | 61748-202-60 |
Proprietary Name | Erythromycin |
Package Description | 60 PACKET in 1 JAR (61748-202-60) > .8 mL in 1 PACKET |
Product NDC | 61748-202 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Erythromycin |
Dosage Form Name | SOLUTION |
Route Name | TOPICAL |
Start Marketing Date | 20100801 |
Marketing Category Name | ANDA |
Labeler Name | VersaPharm Incorporated |
Substance Name | ERYTHROMYCIN |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |